{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:05:19Z","timestamp":1775037919026,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21 NS110647"],"award-info":[{"award-number":["R21 NS110647"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54 NS079202"],"award-info":[{"award-number":["U54 NS079202"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.taap.2021.115643","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T01:38:39Z","timestamp":1626140319000},"page":"115643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The efficacy of \u03b3-aminobutyric acid type A receptor (GABA AR) subtype-selective positive allosteric modulators in blocking tetramethylenedisulfotetramine (TETS)-induced seizure-like behavior in larval zebrafish with minimal sedation"],"prefix":"10.1016","volume":"426","author":[{"given":"Paige C.","family":"Mundy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Pressly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis R.","family":"Carty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Yaghoobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Wulff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela J.","family":"Lein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2021.115643_bb0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0893-133X(98)00052-9","article-title":"Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for \u03b11 versus \u03b12 and \u03b13 subunit-containing GABA(A) receptors","volume":"20","author":"Atack","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.taap.2021.115643_bb0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neuro.2019.12.001","article-title":"Susceptibility of larval zebrafish to the seizurogenic activity of GABA type a receptor antagonists","volume":"76","author":"Bandara","year":"2020","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2021.115643_bb0015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neuroscience.2004.11.031","article-title":"Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression","volume":"131","author":"Baraban","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.taap.2021.115643_bb0020","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1081\/CLT-120026523","article-title":"Status Epilepticus from an Illegally Imported Chinese Rodenticide: \u201cTetramine\u201d","volume":"41","author":"Barrueto","year":"2003","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.taap.2021.115643_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep28674","article-title":"Zolpidem is a potent stoichiometry-selective modulator of \u03b11\u03b23 GABAA receptors: evidence of a novel benzodiazepine site in the \u03b11-\u03b11 interface","volume":"6","author":"Che Has","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2021.115643_bb0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neuroscience.2016.07.018","article-title":"Characterization of the \u03b3-aminobutyric acid signaling system in the zebrafish (Danio rerio Hamilton) central nervous system by reverse transcription-quantitative polymerase chain reaction","volume":"343","author":"Cocco","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.taap.2021.115643_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/toxsci\/kfy266","article-title":"Teratological and behavioral screening of the National Toxicology Program 91-compound library in zebrafish (Danio rerio)","volume":"167","author":"Dach","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2021.115643_bb0040","first-page":"1","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.taap.2021.115643_bb0045","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1124\/jpet.109.161885","article-title":"Limiting activity at \u03b21-subunit-containing GABAA receptor subtypes reduces ataxia","volume":"332","author":"Gee","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2021.115643_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1527-3458.2003.tb00241.x","article-title":"SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms","volume":"9","author":"Griebel","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.taap.2021.115643_bb0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/jpet.113.207324","article-title":"SB-205384 is a positive allosteric modulator of recombinant GABAA receptors containing rat \u03b13, \u03b15, or \u03b16 subunit subtypes Coexpressed with \u03b23 and \u03b32 subunits","volume":"347","author":"Heidelberg","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2021.115643_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2019.01222","article-title":"Isobologram analysis: a comprehensive review of methodology and current research","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2021.115643_bb0065","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/bph.12001","article-title":"A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABAA receptors","volume":"168","author":"Jensen","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2021.115643_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2018.11.020","article-title":"Translational research on chemical nerve agents","volume":"133","author":"Jett","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.taap.2021.115643_bb0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2003.10.054","article-title":"Diazepam reduces both arterial blood pressure and muscle sympathetic nerve activity in human","volume":"355","author":"Kitajima","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.taap.2021.115643_bb0080","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00439-011-1128-0","article-title":"Zebrafish: a model for the study of addiction genetics","volume":"131","author":"Klee","year":"2012","journal-title":"Hum. Genet."},{"key":"10.1016\/j.taap.2021.115643_bb0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/bs.ctdb.2019.02.004","article-title":"Genetic regulation of sex determination and maitenance in zebrafish (Danio rerio)","volume":"134","author":"Kossack","year":"2019","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.taap.2021.115643_bb0090","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bcp.2004.06.040","article-title":"GABAA agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic","volume":"68","author":"Krogsgaard-Larsen","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2021.115643_bb0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1124\/mol.63.2.289","article-title":"Structural requirements for imidazobenzodiazepine binding to GABAA receptors","volume":"63","author":"Kucken","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2021.115643_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2019.104491","article-title":"Tetramethylenedisulfotetramine neurotoxicity: what have we learned in the past 70 years?","volume":"133","author":"Laukov\u00e1","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.taap.2021.115643_bb0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuro.2011.10.008","article-title":"Tetramethylenedisulfotetramine intoxication presenting with de novo status epilepticus: a case series","volume":"33","author":"Li","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2021.115643_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-14-842","article-title":"Tetramine poisoning in China: changes over a decade viewed through the media\u2019s eye","volume":"14","author":"Li","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.taap.2021.115643_bb0115","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1124\/jpet.104.081612","volume":"313","author":"Licata","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2021.115643_bb0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuro.2008.09.011","article-title":"Locomotion in larval zebrafish: influence of time of day, lighting and ethanol","volume":"30","author":"MacPhail","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2021.115643_bb0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0832-5","article-title":"GABAA receptor signalling mechanisms revealed by structural pharmacology","volume":"565","author":"Masiulis","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.taap.2021.115643_bb0130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor \u03b11 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.taap.2021.115643_bb0135","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1152\/jn.00450.2011","article-title":"Molecular basis for the high THIP\/gaboxadol sensitivity of extrasynaptic GABAA receptors","volume":"106","author":"Meera","year":"2011","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.taap.2021.115643_bb0140","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.108.138859","article-title":"NS11394 [3\u2032-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]- biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy","volume":"327","author":"Mirza","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2021.115643_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0196083","article-title":"Expression of the eight GABAA receptor \u03b1 subunits in the developing zebrafish central nervous system","volume":"13","author":"Monesson-Olson","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2021.115643_bb0150","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council (US)","year":"2011"},{"key":"10.1016\/j.taap.2021.115643_bb0155","first-page":"100","article-title":"Anxiolytic-like activity of SB-205384 in the elevated plus maze test in mice","volume":"18","author":"Navarro","year":"2006","journal-title":"Psicothema"},{"key":"10.1016\/j.taap.2021.115643_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-016-0401-x","article-title":"The role of benzodiazepines in the treatment of epilepsy","volume":"18","author":"Ochoa","year":"2016","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.taap.2021.115643_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12302-019-0270-5","article-title":"Hypo- or hyperactivity of zebrafish embryos provoked by neuroactive substances: a review on how experimental parameters impact the predictability of behavior changes","volume":"31","author":"Ogungbemi","year":"2019","journal-title":"Environ. Sci. Eur."},{"key":"10.1016\/j.taap.2021.115643_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/bs.apha.2014.11.005","article-title":"Allosteric ligands and their binding sites define \u03b3-aminobutyric acid (GABA) type a receptor subtypes, 1st ed","author":"Olsen","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.taap.2021.115643_bb0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABAA receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2021.115643_bb0180","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00204-017-2089-4","article-title":"GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS","volume":"92","author":"Pressly","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2021.115643_bb0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/molpharm.120.000090","article-title":"Identification of the functional binding site for the convulsant tetramethylenedisulfotetramine in the pore of the \u03b12\u03b23\u03b32 GABA-A receptor","volume":"99","author":"Pressly","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2021.115643_bb0190","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2021.115643_bb0195","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific \u03b3-aminobutyric acid(a) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.taap.2021.115643_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-84646-3","article-title":"Characterization of zebrafish GABAA receptor subunits","volume":"11","author":"Sadamitsu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2021.115643_bb0205","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/314168a0","article-title":"Co-localization of GABAA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies","volume":"314","author":"Schoch","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.taap.2021.115643_bb0210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1081\/CLT-120030946","article-title":"Flumazenil - Treatment or toxin","volume":"42","author":"Seger","year":"2004","journal-title":"J. Toxicol. - Clin. Toxicol."},{"key":"10.1016\/j.taap.2021.115643_bb0215","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International union of basic and clinical pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: Key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2021.115643_bb0220","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABAA receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2021.115643_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2021.115643_bb0230","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-2999(84)90038-4","article-title":"Benzodiazepine receptor ligand actions on GABA responses. Benzodiazepines, CL 218872, Zopiclone","volume":"101","author":"Skerritt","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2021.115643_bb0235","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cotox.2020.05.004","article-title":"Translational toxicology in zebrafish","volume":"23\u201324","author":"Tal","year":"2020","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.taap.2021.115643_bb0240","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1021\/jm9001154","article-title":"Identification of anxiolytic\/nonsedative agents among indol-3- ylglyoxylamides acting as functionally selective agonists at the \u03b3-aminobutyric acid-a (GABAA) \u03b12 benzodiazepine receptor","volume":"52","author":"Taliani","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2021.115643_bb0245","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/j.bja.2018.12.006","article-title":"Analgesic potential of PF-06372865, an \u03b12\/\u03b13\/\u03b15 subtype-selective GABAA partial agonist, in humans","volume":"123","author":"van Amerongen","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.taap.2021.115643_bb0250","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bph.12151","article-title":"Identification of novel positive allosteric modulators and null modulators at the GABAA receptor \u03b1+\u03b2- interface","volume":"169","author":"Varagic","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2021.115643_bb0255","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2008.08.004","article-title":"Novel compounds selectively enhance \u03b4 subunit containing GABAA receptors and increase tonic currents in thalamus","volume":"56","author":"Wafford","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2021.115643_bb0260","series-title":"The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish Danio (Brachydanio) Rerio","author":"Westerfield","year":"2000"},{"key":"10.1016\/j.taap.2021.115643_bb0265","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.annemergmed.2004.09.009","article-title":"Tetramethylenedisulfotetramine: old agent and new terror","volume":"45","author":"Whitlow","year":"2005","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.taap.2021.115643_bb0270","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(02)01279-7","article-title":"Mechanism of \u03b1-subunit selectivity of benzodiazepine pharmacology at \u03b3-aminobutyric acid type a receptors","volume":"437","author":"Wingrove","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2021.115643_bb0275","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/j.forsciint.2010.06.025","article-title":"Tetramine poisoning: a case report and review of the literature","volume":"204","author":"Zhang","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.taap.2021.115643_bb0280","doi-asserted-by":"crossref","first-page":"8607","DOI":"10.1073\/pnas.1407379111","article-title":"GABAA receptor target of tetramethylenedisulfotetramine","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2021.115643_bb0285","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1111\/j.1556-4029.2010.01625.x","article-title":"Poisoning deaths in Central China (Hubei): a 10-year retrospective study of forensic autopsy cases","volume":"56","author":"Zhou","year":"2011","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.taap.2021.115643_bb0290","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/jpet.111.190579","article-title":"Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine","volume":"341","author":"Zolkowska","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21002477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21002477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:56:22Z","timestamp":1758574582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X21002477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":58,"alternative-id":["S0041008X21002477"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2021.115643","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of \u03b3-aminobutyric acid type A receptor (GABA AR) subtype-selective positive allosteric modulators in blocking tetramethylenedisulfotetramine (TETS)-induced seizure-like behavior in larval zebrafish with minimal sedation","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2021.115643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115643"}}